After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Regenxbio Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Regenxbio Inc is $297.69M. A total of 0.65 million shares were traded on the day, compared to an average of 923.29K shares.
In the most recent transaction, VITTAL VASISTA bought 20,041 shares of RGNX for 7.41 per share on Dec 30 ’24. In a previous transaction on Oct 01 ’24, KARABELAS ARGERIS N sold 10,000 shares at 10.11 per share. RGNX shares that Director owns now total 11,286.
Among the insiders who sold shares, KARABELAS ARGERIS N disposed of 10,000 shares on Sep 03 ’24 at a per-share price of $11.56. This resulted in the Director holding 11,286 shares of RGNX after the transaction. In another insider transaction, KARABELAS ARGERIS N sold 10,100 shares at $13.51 per share on Aug 01 ’24. Company shares held by the Director now total 11,286.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, RGNX has a high of $17.99 and a low of $5.03.
As of this writing, RGNX has an earnings estimate of $0.49 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $1.07 per share and a lower estimate of -$1.21.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RGNX’s latest balance sheet shows that the firm has $457.44M in Cash & Short Term Investments as of fiscal 2021. There were $86.68M in debt and $130.47M in liabilities at the time. Its Book Value Per Share was $5.24, while its Total Shareholder’s Equity was $764.30M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RGNX is Buy with a score of 4.67.
